Please assess the completion status of the following clinical trial:

Trial Title: Bilateral Transforaminal Epidural Steroid Injections for Degenerative Lumbar Spinal Stenosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Symptoms of back/buttock/leg pain (NOT radicular pain) in a neurogenic claudicatory fashion, relieved by stooping or sitting down, for at least 3 months with no or poor response to conservative treatment (analgesics, NSAIDs, or physical therapy)~* Patients with bilateral buttock and/or bilateral lower extremity pain in a neurogenic fashion with or without lower back pain~* Radiologic documentation of degree of degenerative lumbar spinal stenosis (DLSS)~* MRI/CT showing at least moderate central canal spinal stenosis (neuro-radiologist definition) with symptoms correlating with stenosis (symptoms of back/buttock/leg pain without unilateral radicular pain in a neurogenic claudicatory fashion, relieved by stooping or sitting down)~* Patients choosing to receive BTESI as their next treatment option, following discussions with their spine doctor~* Patients who can give informed consent, could tolerate the procedure, and who are able to understand and answer the forms and questionnaires properly.~Exclusion Criteria:~* Radiologic spinal stenosis without symptoms of spinal stenosis~* Symptoms of neurogenic claudication without at least moderate degree of radiologic spinal stenosis~* Patients with specific lumbo-sacral radicular symptoms or radiculopathy (radicular pain secondary to a single nerve root compression/inflammation; usually follows a specific dermatome in lower extremities; unilateral radiculopathy either from disc herniation or lateral recess stenosis)~* Patients with vascular claudication (pain in the legs secondary to arterial insufficiency)~* Previous lumbo-sacral surgery~* Any condition that does not allow the patient to stand and/or walk for any length of time (e.g., COPD, severe lung disease, etc.)~* Patients with symptomatic hip joint pathology concurrent with spinal stenosis~* A coexisting musculoskeletal condition that would negate functional improvement from the injection (e.g., severe Parkinson disease, hemiparesis, etc.)~* Malignancy or infection to the spine~* Another pain generating condition that would mask the improvement provided by the injection~* Patients who had lumbar epidural steroid injections within the past six months~* Significant psychologic diagnosis and/or dementia~* Patients receiving workman's compensation benefit~* Patients unable to give consent on their own, or who are not able to understand and answer the forms and questionnaires, or their answers will not be reliable.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- BTESI (Type: EXPERIMENTAL): a prospective, non-randomized, case series investigating bilateral transforaminal epidural steroid injections (BTESI)

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: feasibility